Comparing Ribociclib versus Palbociclib as a Second Line Treatment in Combination with Fulvestrant in Metastatic Breast Cancer: A Randomised Clinical Trial.

Autor: Ahmed Shaaban, Manar Hamed, Elbaiomy, Mohamed Ali, Eltantawy, Ahmed, Abdel-Fattah, Abdel-Hady El-Gilany, Ahmed Shamaa, Sameh Sayed
Zdroj: Asian Pacific Journal of Cancer Prevention; Sep2024, Vol. 25 Issue 9, p3039-3049, 11p
Databáze: Complementary Index